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Abstract
OBJECTIVE—To determine attitudes of small animal practitioners toward veterinary clinical 
trials and variables influencing their likelihood of participating in such trials.
DESIGN—Cross-sectional survey.
SAMPLE—Small animal practitioners with membership in 1 of 2 online veterinary communities 
(n = 163 and 652).
PROCEDURES—An online survey was developed for each of 2 veterinary communities, and 
invitations to participate were sent via email. Each survey included questions designed to collect 
information on the respondents’ willingness to enroll their patients in clinical trials and to 
recommend participation to clients for their pets.
RESULTS—More than 80% of respondents to each survey indicated that they spend no time in 
clinical research. A high proportion of respondents were likely or extremely likely to recommend 
clinical trial participation to clients for their pets when those trials involved treatments licensed in 
other countries, novel treatments, respected investigators, or sponsoring by academic institutions, 
among other reasons. Reasons for not recommending participation included distance, time 
restrictions, and lack of awareness of ongoing clinical trials; 28% of respondents indicated that 
they did not usually learn about such clinical trials. Most respondents (79% to 92%) rated their 
recommendation of a trial as important to their client’s willingness to participate.
CONCLUSIONS AND CLINICAL RELEVANCE—Participation in veterinary clinical trials by 
small animal practitioners and their clients and patients appeared low. Efforts should be increased 
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to raise practitioner awareness of clinical trials for which patients might qualify. Specific elements 
of trial design were identified that could be modified to increase participation.
Clinical trials are important to the development and testing of treatments in human medicine. 
Through such clinical trials, safety and efficacy of various medical or surgical interventions 
are determined in the applicable target population. In human medicine, recruitment for 
clinical trials is often challenging, with low enrollment rates and often disproportionate 
representation of certain groups, such as people with particular demographic characteristics. 
This difficulty results in a prolonged duration and high financial cost for trials, while also 
limiting the generalizability of any findings.1 Barriers to participation in human clinical 
trials commonly include a lack of awareness of trails for which subjects are being recruited, 
concerns about randomization to a placebo group, and logistical issues, such as 
transportation to clinical trial centers.2–4
In veterinary medicine, clinical trials are equally important, and safety and efficacy data for 
a particular intervention for a particular species cannot be presumed to apply to another 
species. The existence of a profound caregiver placebo effect5–8 further highlights the need 
for recruitment and enrollment strategies that result in clinical trials with representative 
populations and sufficient statistical power to detect any treatment effects that truly exist. 
For an animal to participate, the owner must participate to some extent as well, emphasizing 
the importance of the veterinarian-client-patient relationship. A similar dynamic exists in 
human clinical trials involving individuals unable to provide informed consent, particularly 
pediatric patients.
Much has been written about issues regarding recruitment and consent processes in human 
clinical trials that might extend to veterinary medicine.9,10 Personal relationships with 
physicians and trust in their recommendations can influence people’s decisions to participate 
in a clinical trial.9,10 The reluctance of physicians to enroll patients has been called one of 
the most serious obstacles to trial success, given that patients will rarely participate unless 
actively encouraged by their physician.11,12 Pediatricians’ perceptions of the burden that 
trial participation might have on their patients influence the likelihood of caregivers refusing 
participation, suggesting that subtleties in the language with which a potential trial is 
discussed with caregivers is influential in their decision to enroll.13
In a survey of cat owners,14 several variables were identified to influence the likelihood of 
owners participating in a clinical trial with their cat, including trust in the organization 
performing the trial, whether the cat had a disease that would benefit from the trial, and the 
recommendation of their veterinarian to participate. A large proportion (80%) of cat owners 
said that recommendation from their veterinarian would be important (24%) or extremely 
important (56%) to their participation.
Although several studies4,13,15–17 have been performed to identify variables that influence 
physician enrollment of patients in clinical trials and recommendation of trial participation 
to their patients, this type of research has not yet been thoroughly performed in veterinary 
medicine. The objectives of the study reported here were to survey small animal 
practitioners to ascertain their attitudes toward enrollment of their patients in veterinary 
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clinical trials, particularly the influence of experimental and other trial variables on their 
likelihood of recommending clinical trial participation to clients for their pets.
Materials and Methods
Survey development
Questions for the survey were generated de novo on the basis of expert input and review of 
the human medical literature regarding physician views on clinical research and clinical trial 
participation. Expert input was solicited in 2 phases: first by means of a focus group with 
General Practice Service faculty and faculty members engaged in clinical trials at North 
Carolina State University, and then via feedback from pilot testing and a group of survey 
evaluators at VIN.
An initial 83-item version of the survey was sent to 40 small animal veterinarians known to 
authors for pilot testing, with 35 veterinarians completing the survey. Mean completion time 
for the pilot survey was 26.1 minutes, with 10 respondents indicating that the duration was 
satisfactory. The remaining respondents indicated that the survey was long but feasible (n = 
22), a bit too long (2), or much too long (1). On the basis of their responses, changes were 
made to delete 2 items from the survey and to clarify or improve items as suggested in free-
text responses.
The final survey consisted of 81 items grouped into 8 sections. The first section contained 8 
items for collection of demographic information, and the second section included questions 
about prior clinical trial participation. For questions in the next 5 sections, respondents were 
asked to rate the importance or influence of certain variables in their willingness to 
recommend participation in a veterinary clinical trial to clients for their pets or their opinion 
on the importance of those variables to those clients. Items in the final section were designed 
to gauge the respondent’s general feelings about clinical trials and ideas about the best ways 
to advertise a clinical trial to attract participation and best incentives to encourage owner and 
animal participation.
On August 19, 2014, an email invitation to participate in the 81-item survey was sent to 
1,657 veterinarians and veterinary health professionals whose contact information was 
included in a database maintained by the professional organization VP. Veterinary 
Professionals Ltd is a UK-based company that provides information and advice to pet 
owners and veterinary professionals through its website, books, and continuing professional 
development courses. Veterinary professionals who have accessed any of these resources are 
registered in the database.
The invitation included a link to an online survey,a which allowed for anonymous responses 
(Supplemental Appendix S1, available at: http://avmajournals.avma.org/doi/suppl/10.2460/
javma.250.1.86). The survey link remained active for 2 months, and follow-up invitations 
were emailed to database members twice after the initial invitation (once 2 weeks afterward 
and again 5 weeks afterward).
aFormsite, Vroman Systems Inc, Downers Grove, Ill.
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During the VP survey, the instrument was adapted for distribution to members of an online 
veterinary community (VIN), with suggestions from the VIN survey representative (MR) to 
increase the response rate and geographic distribution of respondents. To increase 
participation, the survey was shortened, while retaining the original language as much as 
possible (Supplemental Appendix S2, available at: http://avmajournals.avma.org/doi/suppl/
10.2460/javma.250.1.86). This survey was created to be more dynamic than its predecessor 
so that a participant’s response to a particular item could direct the presentation of relevant 
subsequent items. All respondents were asked whether they had looked into a clinical trial 
for which recruitment was underway. If the response was no, then respondents were asked 
for the reason. If the response was yes, then respondents were asked whether they had ever 
recommended clinical trial participation to clients for their pets. If the response to that 
question was no, then respondents were asked for the reason. If the response was yes, then 
respondents were asked whether they had ever successfully enrolled clients and their pets 
and about their general perceptions of clinical trials and the impact of certain variables on 
their willingness to promote participation. All respondents, regardless of whether they had 
looked into a clinical trial, were asked about the importance of certain variables on their 
willingness to promote participation and their perception of the importance of certain 
variables to their clients.
On April 9, 2015, an invitation to participate in the VIN survey was emailed to 30,088 VIN 
members (excluding students, academicians, and veterinarians in industry) by use of a list of 
contact information for current members provided by VIN staff, and a reminder invitation 
was sent 2 weeks later. Invitations included a link to an online survey, which allowed for 
anonymous responses.
Statistical analysis
Responses generated through the electronic survey were stored in datasets, which were 
subsequently downloaded for analysis. To reduce the possibility of redundancy in 
respondents, data from VP survey respondents who had identified themselves as VIN 
members were deleted. In addition, all nonveterinarian responses were deleted. Graduation 
dates in the VP survey were manually coded to correspond with the categories used in the 
VIN survey. The VIN categories consisted of 10-year periods, with the exception of the 
period from 2010 through 2014, in which only graduates from the past 5 years were 
represented.
For both surveys, Likert-type responses were converted to an ordinal scale. For items 
concerning importance of a variable (ie, importance items), the scale ranged from 1 (not at 
all important or irrelevant) to 5 (extremely important or essential). For items concerning 
likelihood of a variable (ie, likelihood items), the scale ranged from 1 (most or extremely 
unlikely) to 5 (most or extremely likely). For items concerning agreement with a variable (ie, 
agreement items), the scale ranged from 1 (strongly disagree) to 5 (strongly agree), with 3 
indicating neutral. Responses provided as free text were categorized manually by keyword 
or theme, and those with an identical or common theme were grouped together.
Distributions of responses by graduation-year category were compared by an analysis of 
means of proportions, whereby proportions of respondents within a certain category that 
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were significantly (P < 0.05) higher or lower than the overall mean of all proportions for that 
variable were considered significantly larger or smaller, respectively, than the overall mean 
of all proportions for that variable. For the VP survey and for importance items on the VIN 
survey, frequency of each response category was compared between respondents who had, 
or had not, recommended clinical trial participation to clients in the past by use of the χ2 or 
Fisher exact test, as appropriate. To identify whether general themes or groups of variables 
were associated with being more or less likely to look into or recommend clinical trial 
participation, factor analysis was used, followed by logistic regression. All analyses were 
performed by use of a statistical software program,b and values of P < 0.05 were considered 
significant.
Results
Response rate
A total of 249 people responded to the VP survey, representing a 15% response rate; 815 
people responded to the VIN survey, representing a 3% response rate. To reduce the 
possibility of redundancy among respondents, VP survey respondents who identified 
themselves as VIN members (n = 43) were deleted, leaving 206 respondents in that portion 
of the study. Following removal of incomplete, nonveterinarian, or VIN member responses 
(n = 86), 163 (65%) VP survey respondents had useable data and were included in the study. 
For the VIN survey, 163 surveys were incomplete, yielding 652 (80%) respondents with 
complete data. Given the dynamic application of the VIN survey, the number of responses 
for individual questions varied.
Demographic information
Distributions of graduation year and type of practice among respondents were summarized 
for each survey (Figures 1 and 2). Veterinary practices of VIN survey respondents were 
located mainly in the United States (n = 526 [81%]), with 81 (12%) respondents from 
Canada and 45 (7%) respondents from other countries. The most commonly represented 
other country was Australia (n = 16 [2%]), and no other country was represented by > 5% of 
respondents. In contrast, veterinary practices of VP survey respondents were mainly located 
in the United Kingdom (n = 136 [83%]), with 27 (17%) in other countries (none of which 
had > 5% of respondents). Most respondents to each survey identified themselves as 
veterinarians whose practices were characterized as small animal with or without exotic 
animal (77% and 83% for VIN and VP surveys, respectively) or mixed animal (5% and 4% 
for VIN and VP surveys, respectively).
Time spent in clinical research
Most respondents indicated that they spent no time in clinical research (82% of VIN survey 
respondents and 88% of VP survey respondents) or < 10% of their time in clinical research 
(16% of VIN survey respondents and 5% of VP survey respondents).
bJMP Pro 11.0, SAS Institute, Cary, NC.
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Factors associated with clinical trial participation
VIN survey—In the VIN survey, respondents who had never looked into enrolling a patient 
in a clinical trial (n = 198 [30%]) were asked to indicate a reason; 179 (90%) provided 
responses. The most common specific reasons selected were “Clinical trial centers are too 
far away from my practice” (37%) and “There are no clinical trials or diseases for patients 
that I deal with” (30%). For those who selected the general category other (37%) and entered 
a free-text response, the most common theme was lack of awareness about clinical trials for 
which subjects were being recruited, including which clinical trials were available, the 
process for enrolling a patient in a clinical trial, and where to look for available clinical 
trials.
Respondents who had looked into possibly participating in a clinical trial in the past (n = 
454 [70%]) were asked about the frequency with which they had done this, whether they had 
ever recommended participation to clients for their pets, and whether they had ever 
successfully enrolled a patient in a clinical trial. Of those who had looked into a clinical trial 
in the past, 41% did so less than once a year, 24% did so at least yearly, and 14% did so at 
least semiannually; only 9% did so more frequently. When these respondents were asked 
whether they had ever recommended clinical trial participation to clients for their pets, 87% 
(395/454) responded that they had; 67% (265/395) of respondents who had recommended 
participation reported that they had successfully enrolled at least 1 small animal patient in a 
clinical trial.
The most common reasons provided by respondents who had looked into a clinical trial but 
had not recommended participation to clients (59 respondents; 56 of whom provided 
reasons) were distance to clinical trial centers (68%), lack of availability of clinical trials in 
which their patients might participate (48%), and lack of interest from clients (20%). The 
most common reasons provided by respondents who had recommended participation in the 
past but were unsuccessful in enrolling a patient (130 respondents; 126 of whom provided a 
reason) were distance to clinical trial centers (55%), lack of interest from clients (44%), and 
lack of clinical trials in which their patients might participate (25%). Few (< 1%) 
respondents indicated that clinical trial participation was against current practice policy or 
that they had no time for (3%) or interest in (8%) participating in clinical trials. Less than 
1% of respondents indicated that they did not want to lose the client to the study 
investigators, whereas 6% indicated that their clients were not interested in participating in 
clinical trials.
Across respondents regardless of graduation date category, the overall proportion who had 
looked into participation in a clinical trial was 70%. A significantly (χ2 test; P < 0.001) 
more than expected proportion of respondents who had graduated between 1980 and 1989 
(79%) and between 1990 and 1999 (78%) had looked into enrolling a patient in a clinical 
trial, whereas a lower than expected proportion of respondents in the most recent graduation 
date category (2010 through 2014; 55%) had done the same.
Of respondents who had looked into enrolling a patient in a clinical trial, the overall 
proportion who had recommended clinical trial participation to clients for their pets was 
87%. Significantly (χ2 test; P = 0.001) fewer than expected (73%) respondents in the most 
Gruen et al. Page 6
J Am Vet Med Assoc. Author manuscript; available in PMC 2018 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
recent graduation date category had recommended clinical trial participation. No significant 
(χ2 test; P = 0.07) difference was identified among graduation date categories with respect 
to whether respondents had successfully enrolled their small animal patients into a clinical 
trial.
VP survey—In the VP survey, 44% (72/163) of respondents indicated they had 
recommended clinical trial participation to a client for their pet in the past, and 56% 
(91/163) indicated they had not done so. Respondents in this survey were not asked about 
reasons for not recommending clinical trial participation. No significant (P = 0.07) 
difference in the distribution of respondents by graduation year category was identified 
between those who had or had not recommended clinical trial participation to a client for 
their pet in the past.
Agreement items
Responses to agreement items were asked of 395 of the 653 (61%) VIN survey respondents 
(392 [99%] provided responses) and all 163 VP survey respondents (157 [96%] provided 
responses; Table 1). For either survey, no significant difference in proportions of respondents 
within specific graduation year categories was identified for any item. In general, small 
animal practitioners who had recommended clinical trial participation to clients for their pets 
strongly agreed that clinical trials were important in veterinary medicine or agreed that they 
felt comfortable discussing clinical trials and informed consent with their clients.
When asked about their level of agreement with a series of statements, most VIN survey 
respondents disagreed or strongly disagreed that anecdotal information is sufficient to 
support most therapies (76%) and that their clients were aware of veterinary clinical trials in 
which they might participate (76%). In the VP survey, no significant difference in 
distributions of responses to most agreement items was identified between respondents who 
had or had not recommended clinical trial participation to their clients for their pets in the 
past. However, in response to the statement, “I feel comfortable discussing clinical trials and 
informed consent with my clients,” significantly (χ2 test; P = 0.002) lower agreement was 
identified for respondents who had not (vs had) previously recommended participation 
(Table 2).
The VIN survey respondents who had recommended clinical trial participation to clients for 
their pets in the past (n = 395; 59 responded that they had not done so) and all VP survey 
respondents were asked to rate the likelihood that they would recommend clinical trial 
participation on the basis of certain experimental, methodological, and additional elements 
(Table 3). For the VP survey, no significant differences in the distribution of responses were 
identified between those who had and had not recommended clinical trial participation to a 
client in the past, except for 1 additional item, “Trial is run by a respected investigator,” to 
which respondents who had recommended clinical trial participation provided responses that 
indicated this would make them more likely to recommend a trial.
With respect to experimental variables, responses to the VP survey were generally in the 
same direction as for the VIN survey. The exception was “Trial involves a rare disease,” for 
which a high proportion of VP survey responses were in the less likely range of the Likert 
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scale, whereas in the VIN survey, a high proportion were in the more likely range. With 
respect to methodological variables, high proportions (> 50%) of responses were in the more 
likely range. A high proportion of survey respondents were less likely to recommend clinical 
trial participation to their clients when the trial involved invasive sample collection (VIN and 
VP survey respondents) or disruption of daily activity (VIN survey respondents only).
With respect to additional variables, the distribution of responses to all variables was in the 
same direction from neutral agreement for both surveys, except for “Trial is funded by a 
corporation or industry.” In that situation, the distributions of responses to the VP survey 
were at or below neutral and those to the VIN survey were above neutral. Only 1 additional 
variable from the VIN survey, “Trial is not funded,” had a majority (84%) of responses in 
the neutral or below (less likely) categories. Across both surveys, the top 3 variables that 
increased the likelihood of respondents recommending clinical trial participation to their 
clients included a respected investigator running the trial, a promise to inform the 
veterinarian of the trial results, and sponsoring of the trial by an academic institution.
In the VP survey, a significant (Fisher exact test; P = 0.042) difference was identified in the 
distribution of responses to a respected investigator running the trial between those who had 
or had not recommended participation to clients for their pets in the past, with the 
distribution of responses shifted more toward the neutral range of the scale for those who 
had not recommended clinical trial participation in the past (Table 2).
Importance items
A total of 765 respondents (618 from the VIN survey and 147 from the VP survey) provided 
usable responses to prompts regarding the importance of certain variables, either to 
themselves in their decision to recommend clinical trial participation to a client or to their 
clients in considering participation. Because of the limited number of VP survey 
respondents, factor analysis was performed on responses to these importance items in the 
VIN survey only.
With respect to the decision to recommend clinical trial participation to clients for their pets, 
variables receiving a higher proportion of responses in the high importance range of the 
scale included belief in the value of the study, concern about putting the study needs and 
protocol before the pet’s needs, and inconvenience to the owner. With respect to their clients 
considering participation, such variables included the pet having a disease that could benefit 
from the trial, safety of the treatment, cost of participation, distance to the trial center, and 
chance of pet being placed in the placebo group (VIN survey), among others (Table 4). A 
high proportion (37%) of VIN survey respondents rated 1 variable, the need for the pet to be 
unfed for recheck examinations, as less important to owners, suggesting that the respondents 
did not believe that withholding food from a pet would be difficult for owners to accomplish.
For both surveys, significant differences were identified in the distributions of responses 
regarding certain variables between respondents who had and had not recommended clinical 
trial participation to clients for their pets in the past (Table 2), with remarkable concordance 
between the 2 surveys. Variables with concordant data included concern about putting the 
study needs and protocol before the pet’s needs, concern about the respondent’s relationship 
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with the client, loss of trust from a client, loss of control of case management, and time 
required to explain the trial to the client.
Factor analysis of importance items from the VIN survey
Factor analysis across the 22 importance items was performed for responses to the VIN 
survey for which complete data were provided (n = 609 [93%]). Six factors explained 61% 
of the total variance in responses (Table 5).
A logistic regression model was fit with the probability that a respondent had looked into 
enrolling a patient in a clinical trial as the response variable; 434 respondents had done so, 
whereas 175 had not. Factors 2 (P = 0.002), 3 (P < 0.001), and 4 (P = 0.005) were all 
significantly associated with looking into patient enrollment. Each factor represented a 
mixture of positive and negative influences on the overall factor score—influences that 
appeared to group together. These factors were deemed to represent the following themes: 
factor 2, veterinarian-client-pet relationship (positive loading) and features related to 
logistics (negative loading); factor 3, features important to the client (positive loading) and 
features related to time (negative loading); and factor 4, features related to time. Increases in 
factor 2 (OR, 1.34; Wald 95% CI, 1.12 to 1.61) and factor 3 (OR, 1.45; Wald 95% CI, 1.20 
to 1.74) were associated with an increased likelihood of looking into patient enrollment, 
whereas an increase in factor 4 was associated with a decreased likelihood of looking into 
patient enrollment (OR, 0.78; Wald 95% CI, 0.65 to 0.93).
Clinical trial awareness
VIN survey—In the VIN survey, all respondents were asked how they obtained information 
about clinical trials for which subjects were being recruited and the most effective ways to 
promote clinical trial participation to veterinarians in their area; 606 provided responses. At 
least 40% of respondents indicated that they obtained information about veterinary clinical 
trials from email notifications, word of mouth, and promotions on VIN. Twenty-eight 
percent (170/606) responded that they did not usually learn or know of clinical trials in their 
area. For the most effective ways to advertise subject recruitment for clinical trials, 70% of 
respondents selected email to the practice, 60% selected a clinical trials website, and 54% 
selected printed information sent to the practice. Only 43% selected a visit from the study 
investigator.
VP survey—In the VP survey, respondents were also asked how they obtained information 
about clinical trials in their area and for their opinion on the 2 most effective ways to 
promote clinical trial participation to veterinarians in their area. As in the VIN survey, 36% 
of respondents indicated that they did not typically learn of clinical trials in their area; 37% 
selected email and 25% selected mailed flyers as the most effective advertising strategies for 
educating them about clinical trials. Forty-six percent of respondents indicated that they 
obtained information about available clinical trials through journals; this option was not 
provided in the VIN survey. Opinions regarding the most effective ways to promote clinical 
trials were somewhat different from those in the VIN survey, with 45% of respondents 
selecting email to the practice and 54% selecting a visit from the study investigator. Only 
Gruen et al. Page 9
J Am Vet Med Assoc. Author manuscript; available in PMC 2018 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
20% selected a clinical trials website for the region, whereas 30% indicated that continuing 
education seminars would be effective.
Respondents in the VP survey were also asked about their overall feelings regarding clinical 
trials in veterinary medicine as well as the incentives they believed would be best for 
encouraging pet and owner participation, with 140 providing responses. Overall, 75% 
(105/140) of respondents had positive feelings about clinical trials in veterinary medicine, 
with 23% having neutral (32/140) and only 2% having negative (3/140) feelings. Most 
respondents (122/140 [87%]) selected free services (eg, laboratory tests, radiographs, or 
examinations) as the best owner incentive for participation with their pet in a clinical trial.
Discussion
The present study revealed that small animal practitioners are interested in veterinary 
clinical trials, and several variables associated with those trials were important and 
influential in their decision to recommend clinical trial participation to clients for their pets. 
The study represents the first of its kind in veterinary medicine, although similar studies 
have been conducted in human medicine.
Responses to several survey items were restricted to respondents who had recommended 
clinical trial participation in the past because this subset of small animal practitioners was 
considered more likely to recommend clinical trial participation than those who had not 
made such a recommendation. This subset was also considered the group for whom it would 
be most valuable to explore the elements of clinical trials that influence the likelihood of 
recommendation.
Overall, agreement was high that veterinary clinical trials are important and that small 
animal practitioners feel comfortable discussing informed consent. This finding was 
expected, although lower agreement could have existed for respondents who had not 
previously looked into or recommended clinical trial participation in the past. That 
possibility could not be evaluated with the data obtained in the VIN survey, but responses to 
the VP survey for items pertaining to comfort discussing clinical trials and informed consent 
were generally more negative for small animal practitioners who had not (vs had) 
recommended clinical trial participation in the past. In human medicine, a physician’s lack 
of confidence in explaining clinical trials to patients is a reported barrier to trial 
recruitment.18
Small animal practitioners who had recommended clinical trial participation to clients did 
not generally believe that their clients would be “fearful about participating in a clinical 
trial,” although 78% disagreed or strongly disagreed that their clients were aware of 
veterinary clinical trials in the recruitment phase. This is in agreement with findings from a 
survey11 involving pediatricians, in which respondents believed that community awareness 
of randomized clinical trials in the recruitment phase was low. Even among those veterinary 
practitioners who strongly believed that clinical trials are important and who had actively 
recommended participation to patients, some degree of failure to recommend participation 
was identified, given that only 49% agreed or strongly agreed that veterinarians should 
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recommend clinical trial participation to clients for their pets as often as possible, whereas 
34% agreed that veterinarians should recommend participation only to select clients (Table 
1).
Failure to recommend a trial to potential participants is a considerable problem in the subject 
recruitment stage of clinical trials in human medicine, even for groups of clinical trial 
investigators.19 Reasons for failure to recommend participation in human clinical trials 
include concerns about characteristics of the project or protocol, perceptions of the patient or 
family, and anticipated refusal of patients to participate. Protocol-related concerns in human 
clinical trials include the involvement of invasive procedures (including blood sample 
collection), inclusion of a placebo group, and randomization.2,11,20
In the present study, small animal practitioners generally gave no indication that any of the 
specified clinical trial elements would make them less likely to recommend clinical trial 
participation. The exceptions were a trial that was not funded (VIN survey) or involved 
invasive sample collection or a rare disease (VP survey). However, shifts in response 
distributions toward a lower likelihood of recommending participation (or a more negative 
influence) were evident for trials involving a new treatment for a condition with a currently 
successful therapy, and those that involved invasive sample collection or interfered 
moderately with daily activities. Respondents believed that the chance of the pet being 
placed in a placebo group was important to clients in considering a clinical trial (74 selected 
important or extremely important), but whether this variable influenced the decision to 
recommend participation was not examined.
Nearly 30% of VIN survey respondents stated that they did not generally learn of clinical 
trials being conducted in their area. In addition, among the most common reasons given for 
not looking into or recommending clinical trial participation were lack of awareness of the 
trials and the process for enrolling a patient. Similarly, distance to clinical trial centers was 
selected as a reason for not looking into clinical trial participation by 37% of VIN 
respondents and by nearly 70% of those who had looked into enrolling patients in a trial but 
had not recommended it to clients. However, respondents were not asked to define their 
perception of a clinical trial center, which could have included referral hospitals, 
universities, or private clinics. Future research should incorporate additional questions to 
determine how and where veterinarians believe clinical trials are conducted, given that this 
may represent an educational opportunity. For human clinical trials, proximity to a clinical 
trial center has been associated with increased likelihood of physician referral of patients 
with Alzheimer disease for trials.20
In the present study, positive influences on recommending trial participation included 
running of the trial by a respected investigator, sponsoring of the trial by an academic 
institution, and promises to inform participating small animal practitioners about the trial 
results. This suggested that increasing communication between trial investigators and 
veterinary practitioners could facilitate subject recruitment to veterinary clinical trials.21
Population attitudes and beliefs often manifest as latent traits that can be only indirectly and 
sometimes imperfectly measured by use of standard questionnaires. Factor analysis is a 
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method for estimating these latent traits from question-level survey data by determining the 
question responses that group together. Results of factor analysis in the present study 
indicated that response items with high loading for a certain factor were thematically related 
and that small animal practitioners’ beliefs about the importance of these factors may have 
influenced whether they recommend clinical trial participation to their clients. Only the 
factors that had a significant relationship with the likelihood of a veterinarian looking into 
clinical trial participation were considered, as they were the only factors providing 
meaningful insight into the characteristics of the population studied. Overall, higher scores 
on factors 2 and 3 (representing relatively higher scores for issues related to doctor-client 
relationship and lower scores for logistical issues and relatively higher scores for features 
believed to be important to the client and lower scores for issues related to time, 
respectively) were associated with an increased likelihood of respondents looking into 
enrolling a patient in a clinical trial. On the other hand, a higher score on factor 4 (appearing 
to represent variables related to time) was associated with a decreased likelihood of a 
respondent looking into enrolling a patient in a clinical trial.
Concerns related to time investment required for trial participation are important to 
acknowledge in general veterinary practice, where free time is often restricted and the time 
needed to look into trials, discuss trials with owners, and pursue participation may be a 
strain for veterinarians when avenues for identifying upcoming trials for which subjects are 
being actively recruited and the requirements for those trials are not clearly outlined. This 
problem has been identified in studies4,22–24 concerning clinical trials in human medicine as 
well. For example, a study13 involving pediatricians revealed that spending more time in the 
initial interview or discussion with potential clinical trial participants led to lower refusal 
rates, which is a strategy that is not always feasible in busy general practices.
In the present study, respondents’ ratings of importance items highlighted several variables 
they believed to be extremely important to clients in considering clinical trial participation 
with their pets. The variable that received the highest importance rating in the VIN survey 
was having a pet with a condition that could benefit from the trial, reported by 71% of 
respondents. This finding was similar to that in a study14 of cat owners’ views on clinical 
trial participation, in which 73% of respondents gave this item the highest importance rating 
(5-point scale). Veterinarian endorsement of the trial was also rated as important, although 
only 33% of VIN survey respondents and 26% of VP survey respondents gave this the 
highest importance rating. This finding was likely an underestimation, given that physician 
recommendation has been cited as a critical feature of clinical trial participation in human 
medicine,11 and in the study14 of cat owners, 56% assigned the highest importance rating (5-
point scale) to the item “My veterinarian recommended the trial.” Additional research would 
be useful to compare attitudes of pet owners (including dog owners) with attitudes of small 
animal practitioners to identify commonalities (and gaps) between importance ratings.
A few studies11,21,25,26 in human medicine have involved use of small groups of physicians 
and more in-depth discussions to explore attitudes toward clinical research. Although such 
studies generally have far fewer participants, the ability to ask follow-up questions can 
provide details not accessible through a survey tool, even with free-text options. This 
approach could be explored in veterinary medicine.
Gruen et al. Page 12
J Am Vet Med Assoc. Author manuscript; available in PMC 2018 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
The present study had several limitations. Considering the number of veterinarians in small 
animal practice, overall participation and response rate in the survey were low; however, the 
number of participants was similar to that in another veterinary survey.26 These 
characteristics may have limited the ability to generalize the findings to a broader 
veterinarian population. Also, studies involving internet-based surveys are subject to 
volunteer bias, whereby the attitudes of those who participate might not represent the 
attitudes of those who declined participation or the target population.
Several items on the VIN survey were asked only of respondents who had recommended 
clinical trial participation to clients, so it remains unknown how small animal practitioners 
who had not recommended participation would have rated the same items. Differences in 
response patterns were identified between VIN survey and VP survey respondents, which 
might have been attributable to differences in the survey instruments or differences in the 
populations from which respondents were selected. Given these differences, it was not 
possible to make direct comparisons between results from these surveys. Although all 
respondents were veterinarians, and the majority from each survey self-identified their 
practices as small animal practice, exotic animal practice, or both, differences aside from 
country of residence may have existed. In the future, efforts to obtain international 
participation on the same survey instrument delivered in the same manner could be helpful 
in the evaluation of potential geographical differences in attitudes. Respondents in the 
present study were also limited to small animal practitioners, and findings for other types of 
practitioners toward clinical trials in their own specialties could be expected to differ from 
those reported here.
Despite the aforementioned limitations, results of the present study emphasized the 
importance of understanding the elements of clinical trials that are important to small animal 
practitioners and those that they believe are important to clients as well. Opportunities exist 
to improve the awareness small animal practitioners regarding clinical trials for which 
subjects are being recruited, and a means of achieving this may be through a searchable 
clinical trials website or registry, such as that initiated by the AVMA.27 Conduction of 
clinical trials at multiple rather than single sites could also help to minimize the distance that 
clients would need to travel with their pets to participate, thereby increasing the likelihood of 
small animal practitioners successfully enrolling patients or recommending participation to 
clients. In addition, development of educational materials designed to streamline the 
practitioner’s discussion of a clinical trial with clients could help to provide information, 
raise awareness, and relieve some of the time constraints that hinder clinical trial 
recruitment.
Results also suggested that even when small animal practitioners were aware of a clinical 
trial, they may not have attempted to enroll patients if they did not believe in the value of the 
study or distrusted other protocol or patient care elements. Additional research is needed to 
investigate the impact of interventions, such as increasing involvement of small animal 
practitioners in study design and communication of results, on recruitment efforts.
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Figure 1. 
Distribution of year of graduation for small animal practitioners who responded to an online 
VP (n = 163) or VIN (652) survey regarding attitudes toward enrolling their patients in 
veterinary clinical trials.
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Figure 2. 
Distribution of practice types for small animal practitioners who responded to an online VP 
(n = 163) or VIN (652) survey regarding attitudes toward enrolling their patients in 
veterinary clinical trials.
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